Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |